[EN] CELL ENTRY-MODULATING AGENTS AND USES THEREFOR<br/>[FR] AGENTS MODULATEURS DE L'ENTRÉE CELLULAIRE ET LEURS UTILISATIONS
申请人:UNIV GRIFFITH
公开号:WO2021222988A1
公开(公告)日:2021-11-11
The present disclosure relates to peptides comprising an amino acid sequence set forth in SEQ ID NO: 1 or 2. Methods of using these peptides to treat or prevent an infection caused by an angiotensin-converting enzyme 2 (ACE2)-interacting coronavirus, elicit an immune response to an ACE2-interacting coronavirus, detect an infection by an ACE2-interacting coronavirus, or identify agents which inhibit the interaction of an ACE2-interacting coronavirus with the ACE2 receptor, are further disclosed. Furthermore, this disclosure pertains to methods of treating a coronavirus infection comprising the administration of an ACE2- interacting compound, and novel compounds for this purpose.